Dr. Tarun K Sharma, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 195 Us Highway 46 Ste 100, Mine Hill, NJ 07803 Phone: 973-366-7330 Fax: 973-306-3043 |
Dr. Aristides M Estrada, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Route #46, Ste #102, Mine Hill, NJ 07803 Phone: 973-366-6060 Fax: 973-366-1423 |
Dr. Andreas D Rotsides, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Us Highway 46, Suite 200, Mine Hill, NJ 07803 Phone: 973-328-1040 Fax: 973-328-1544 |
Nicholas S. Albicocco, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 195 Us Highway 46, Suite 203, Mine Hill, NJ 07803 Phone: 973-366-7330 Fax: 973-989-0508 |
John Brent Forward, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Route #46, Ste #102, Mine Hill, NJ 07803 Phone: 973-366-6060 Fax: 973-366-1423 |
Dr. Subramoni Sundaram, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Us Highway 46, Suite 101, Mine Hill, NJ 07803 Phone: 973-361-2550 Fax: 973-361-0066 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizantâ„¢ (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults. Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night.
Republicans cast the debate over mandatory coverage as one of religious freedom, while Democrats frame it as a matter of women's health.
Without hands-on access to doctors and hospitals, oil rig workers who become sick or injured increasingly rely on telemedicine "visits" with physicians and specialists on land, a trend explored in detail in an article published in Telemedicine and e-Health, a peer-reviewed journal published by Mary Ann Liebert, Inc.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today that the U.S. District Court for the Eastern District of Texas has granted a preliminary injunction ordering Par Pharmaceutical Inc. not to make, use, sell, offer to sell, or import into the United States a generic version of sumatriptan/naproxen sodium that competes with Treximet sold by GlaxoSmithKline in the United States under an exclusive license from the Company.
Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.
› Verified 5 days ago